Mcf Advisors LLC Mirum Pharmaceuticals, Inc. Transaction History
Mcf Advisors LLC
- $1.42 Billion
- Q4 2024
A detailed history of Mcf Advisors LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 203 shares of MIRM stock, worth $9,648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
203
Previous 203
-0.0%
Holding current value
$9,648
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
193Shares Held
54.1MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$312 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$213 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$164 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$154 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$146 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.75B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...